Literature DB >> 30836422

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Zhongxun Shi1,2, Bing Li1,2, Huijun Huang1,2, Tiejun Qin1, Zefeng Xu1,2, Hongli Zhang1, Liwei Fang1, Lijuan Pan1, Naibo Hu1, Shiqiang Qu1, Gang Huang3, Robert P Gale4, Zhijian Xiao1,2.   

Abstract

Entities:  

Keywords:  genetic mutation; myelodysplastic syndrome; prognosis; red blood cell distribution width

Mesh：

Year:  2019        PMID： 30836422      PMCID： PMC9206236          DOI： 10.1111/bjh.15830

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  7 in total

1.  Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach.

Authors:  David de Gonzalo-Calvo; Beatriz de Luxán-Delgado; Susana Rodríguez-González; Marina García-Macia; Francisco Manuel Suárez; Juan José Solano; María Josefa Rodríguez-Colunga; Ana Coto-Montes
Journal:  Cytokine       Date:  2012-02-05       Impact factor: 3.861

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

4.  New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes.

Authors:  Mintallah Haider; Eric J Duncavage; Khalid F Afaneh; Rafael Bejar; Alan F List
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?

Authors:  Bing Li; Jinqin Liu; Zefeng Xu; Tiejun Qin; Zhongxun Shi; Zhen Song; Huijun Huang; Liwei Fang; Hongli Zhang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Yue Zhang; Gang Huang; Zhijian Xiao
Journal:  Br J Haematol       Date:  2017-11-28       Impact factor: 8.615

7.  Prediction of acute myeloid leukaemia risk in healthy individuals.

Authors:  Sagi Abelson; Grace Collord; Stanley W K Ng; Omer Weissbrod; Netta Mendelson Cohen; Elisabeth Niemeyer; Noam Barda; Philip C Zuzarte; Lawrence Heisler; Yogi Sundaravadanam; Robert Luben; Shabina Hayat; Ting Ting Wang; Zhen Zhao; Iulia Cirlan; Trevor J Pugh; David Soave; Karen Ng; Calli Latimer; Claire Hardy; Keiran Raine; David Jones; Diana Hoult; Abigail Britten; John D McPherson; Mattias Johansson; Faridah Mbabaali; Jenna Eagles; Jessica K Miller; Danielle Pasternack; Lee Timms; Paul Krzyzanowski; Philip Awadalla; Rui Costa; Eran Segal; Scott V Bratman; Philip Beer; Sam Behjati; Inigo Martincorena; Jean C Y Wang; Kristian M Bowles; J Ramón Quirós; Anna Karakatsani; Carlo La Vecchia; Antonia Trichopoulou; Elena Salamanca-Fernández; José M Huerta; Aurelio Barricarte; Ruth C Travis; Rosario Tumino; Giovanna Masala; Heiner Boeing; Salvatore Panico; Rudolf Kaaks; Alwin Krämer; Sabina Sieri; Elio Riboli; Paolo Vineis; Matthieu Foll; James McKay; Silvia Polidoro; Núria Sala; Kay-Tee Khaw; Roel Vermeulen; Peter J Campbell; Elli Papaemmanuil; Mark D Minden; Amos Tanay; Ran D Balicer; Nicholas J Wareham; Moritz Gerstung; John E Dick; Paul Brennan; George S Vassiliou; Liran I Shlush
Journal:  Nature       Date:  2018-07-09       Impact factor: 49.962
  7 in total
  3 in total

1.  Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes.

Authors:  Qiuni Chen; Yue Chen; Yijing Zhang; Lijuan Zhang; Kankan Chen; Zhengmei He; Chunling Wang; Liang Yu
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

2.  The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia.

Authors:  Vladan Vucinic; Leo Ruhnke; Katja Sockel; Maximilian Alexander Röhnert; Donata Backhaus; Dominic Brauer; Georg-Nikolaus Franke; Dietger Niederwieser; Martin Bornhäuser; Christoph Röllig; Uwe Platzbecker; Sebastian Schwind; Madlen Jentzsch
Journal:  Blood Adv       Date:  2021-12-28

3.  The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome.

Authors:  Atakan Turgutkaya; Nesim Akın; Gökhan Sargın; Zahit Bolaman; İrfan Yavaşoğlu
Journal:  Hematol Transfus Cell Ther       Date:  2021-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.